These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21270132)

  • 1. The case for randomized controlled trials to assess the impact of clinical information systems.
    Liu JL; Wyatt JC
    J Am Med Inform Assoc; 2011; 18(2):173-80. PubMed ID: 21270132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-utility analysis conducted alongside randomized controlled trials: are economic end points considered in sample size calculations and does it matter?
    Hollingworth W; McKell-Redwood D; Hampson L; Metcalfe C
    Clin Trials; 2013 Feb; 10(1):43-53. PubMed ID: 23231969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact Research - how to choose experimental or observational intervention study?
    Malmivaara A
    Ann Med; 2016 Nov; 48(7):492-495. PubMed ID: 27494394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cohort multiple randomized controlled trial design: a valid and efficient alternative to pragmatic trials?
    van der Velden JM; Verkooijen HM; Young-Afat DA; Burbach JP; van Vulpen M; Relton C; van Gils CH; May AM; Groenwold RH
    Int J Epidemiol; 2017 Feb; 46(1):96-102. PubMed ID: 27118559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research.
    Chalkidou K; Tunis S; Whicher D; Fowler R; Zwarenstein M
    Clin Trials; 2012 Aug; 9(4):436-46. PubMed ID: 22752634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Complex Health Interventions With Randomized Controlled Trials: How Do We Improve the Use of Qualitative Methods?
    Mannell J; Davis K
    Qual Health Res; 2019 Apr; 29(5):623-631. PubMed ID: 30871431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent design and conduct of clinical trials.
    Yusuf S; Bosch J
    Clin Trials; 2006; 3(6):503-7. PubMed ID: 17170033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation.
    Goldstein CE; Weijer C; Brehaut JC; Fergusson DA; Grimshaw JM; Horn AR; Taljaard M
    BMC Med Ethics; 2018 Feb; 19(1):14. PubMed ID: 29482537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of randomised controlled trials for producing cost-effectiveness evidence: potential impact of design choices on sample size and study duration.
    Backhouse ME
    Pharmacoeconomics; 2002; 20(15):1061-77. PubMed ID: 12456201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.
    Lam KC; Bacon CEW; Sauers EL; Bay RC
    J Athl Train; 2020 Mar; 55(3):217-228. PubMed ID: 31618071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good intentions and received wisdom are not good enough: the need for controlled trials in public health.
    Macintyre S
    J Epidemiol Community Health; 2011 Jul; 65(7):564-7. PubMed ID: 21148137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's in a gold standard? In defence of randomised controlled trials.
    Backmann M
    Med Health Care Philos; 2017 Dec; 20(4):513-523. PubMed ID: 28432483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster randomized trials: another problem for cost-effectiveness ratios.
    Flynn TN; Peters TJ
    Int J Technol Assess Health Care; 2005; 21(3):403-9. PubMed ID: 16110722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research Methods in Healthcare Epidemiology and Antimicrobial Stewardship: Randomized Controlled Trials.
    Anderson DJ; Juthani-Mehta M; Morgan DJ
    Infect Control Hosp Epidemiol; 2016 Jun; 37(6):629-34. PubMed ID: 27108848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to improve antibiotic prescribing practices for hospital inpatients.
    Davey P; Marwick CA; Scott CL; Charani E; McNeil K; Brown E; Gould IM; Ramsay CR; Michie S
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD003543. PubMed ID: 28178770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.